These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 21381184)

  • 1. Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy.
    Colvin L; Slack-Smith L; Stanley FJ; Bower C
    Birth Defects Res A Clin Mol Teratol; 2011 Mar; 91(3):142-52. PubMed ID: 21381184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.
    Colvin L; Slack-Smith L; Stanley FJ; Bower C
    CNS Drugs; 2012 Jul; 26(7):e1-14. PubMed ID: 22712699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective serotonin reuptake inhibitor prescribing before, during and after pregnancy: a population-based study in six European regions.
    Charlton RA; Jordan S; Pierini A; Garne E; Neville AJ; Hansen AV; Gini R; Thayer D; Tingay K; Puccini A; Bos HJ; Nybo Andersen AM; Sinclair M; Dolk H; de Jong-van den Berg LT
    BJOG; 2015 Jun; 122(7):1010-20. PubMed ID: 25352424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs associated with teratogenic mechanisms. Part I: dispensing rates among pregnant women in the Netherlands, 1998-2009.
    van Gelder MM; Bos JH; Roeleveld N; de Jong-van den Berg LT
    Hum Reprod; 2014 Jan; 29(1):161-7. PubMed ID: 24105826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks associated with selective serotonin reuptake inhibitors in pregnancy.
    Malm H; Klaukka T; Neuvonen PJ
    Obstet Gynecol; 2005 Dec; 106(6):1289-96. PubMed ID: 16319254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors.
    Grzeskowiak LE; Gilbert AL; Morrison JL
    J Clin Psychopharmacol; 2012 Oct; 32(5):615-21. PubMed ID: 22926594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.
    Bakker MK; Kölling P; van den Berg PB; de Walle HE; de Jong van den Berg LT
    Br J Clin Pharmacol; 2008 Apr; 65(4):600-6. PubMed ID: 17953715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to selective serotonin reuptake inhibitors in early pregnancy and the risk of miscarriage.
    Andersen JT; Andersen NL; Horwitz H; Poulsen HE; Jimenez-Solem E
    Obstet Gynecol; 2014 Oct; 124(4):655-661. PubMed ID: 25198261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obstetrical and neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitors: the relevance of dose.
    Roca A; Garcia-Esteve L; Imaz ML; Torres A; Hernández S; Botet F; Gelabert E; Subirà S; Plaza A; Valdés M; Martin-Santos R
    J Affect Disord; 2011 Dec; 135(1-3):208-15. PubMed ID: 21890210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of selective serotonin reuptake inhibitors (SSRIs) in women delivering liveborn infants and other women of child-bearing age within the U.S. Food and Drug Administration's Mini-Sentinel program.
    Andrade SE; Reichman ME; Mott K; Pitts M; Kieswetter C; Dinatale M; Stone MB; Popovic J; Haffenreffer K; Toh S
    Arch Womens Ment Health; 2016 Dec; 19(6):969-977. PubMed ID: 27178125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.
    Louik C; Lin AE; Werler MM; Hernández-Díaz S; Mitchell AA
    N Engl J Med; 2007 Jun; 356(26):2675-83. PubMed ID: 17596601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SSRI use during pregnancy and risk of stillbirth and neonatal mortality.
    Jimenez-Solem E; Andersen JT; Petersen M; Broedbaek K; Lander AR; Afzal S; Torp-Pedersen C; Poulsen HE
    Am J Psychiatry; 2013 Mar; 170(3):299-304. PubMed ID: 23361562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries.
    Kieler H; Artama M; Engeland A; Ericsson O; Furu K; Gissler M; Nielsen RB; Nørgaard M; Stephansson O; Valdimarsdottir U; Zoega H; Haglund B
    BMJ; 2012 Jan; 344():d8012. PubMed ID: 22240235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.
    Furu K; Kieler H; Haglund B; Engeland A; Selmer R; Stephansson O; Valdimarsdottir UA; Zoega H; Artama M; Gissler M; Malm H; Nørgaard M
    BMJ; 2015 Apr; 350():h1798. PubMed ID: 25888213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
    Bérard A; Zhao JP; Sheehy O
    BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study.
    Nordeng H; van Gelder MM; Spigset O; Koren G; Einarson A; Eberhard-Gran M
    J Clin Psychopharmacol; 2012 Apr; 32(2):186-94. PubMed ID: 22367660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of antidepressant medications during pregnancy: a multisite study.
    Andrade SE; Raebel MA; Brown J; Lane K; Livingston J; Boudreau D; Rolnick SJ; Roblin D; Smith DH; Willy ME; Staffa JA; Platt R
    Am J Obstet Gynecol; 2008 Feb; 198(2):194.e1-5. PubMed ID: 17905176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality.
    Stephansson O; Kieler H; Haglund B; Artama M; Engeland A; Furu K; Gissler M; Nørgaard M; Nielsen RB; Zoega H; Valdimarsdóttir U
    JAMA; 2013 Jan; 309(1):48-54. PubMed ID: 23280224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant drug exposure during pregnancy. CZTIS small prospective study.
    Manakova E; Hubickova L
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():53-6. PubMed ID: 22167208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.